NEW YORK (GenomeWeb News) – Syapse and N-of-One announced a partnership today that will allow both companies to combine their respective products into an integrated informatics solution for clinical data interpretation.
The newly inked deal will make N-of-One's clinical interpretation capabilities available to hospitals and laboratories through the Syapse for Labs and Syapse for Hospitals products. The integration, they said, will provide pathologists and treating physicians with tools to integrate molecular interpretation information into their workflows and to translate that data into actionable therapeutic strategies for cancer.
"By partnering with Syapse … we will be able to provide N-of-One clinical insights in a way that optimizes the workflow of clinicians, and thus helps drive the adoption of precision medicine in oncology," Chris Cournoyer, N-of-One's CEO, said in a statement.
Financial and other terms of the agreement were not disclosed